Skin Cancer Drug Shows Promise
Thursday, June 10th, 2010Researchers were recently happy to announce that an experimental drug called ipilimumab, (ip-ee-LIM-uh-mab), has shown to significantly improve survival rates in people with advanced melanoma – the deadliest form of skin cancer.
The drug works by helping the immune system fight tumors. The FDA has pledged a quick review, and doctors are hopeful that the drug could be available by the end of 2010.
“We have not had any therapy that has prolonged survival” until now, said Dr. Lynn Schuchter of the Abramson Cancer Center at the University of Pennsylvania, a skin cancer specialist with no role in the study or ties to the drug’s maker.
Melanoma is the most serious form of skin cancer. Last year in the US, there were about 68,000 new cases and 8,650 deaths from the disease. Worldwide, more than 50,000 people die of melanoma each year.
“The incidence is rising faster than any other cancer,” said one of the study’s leaders, Dr. Stephen Hodi of Dana-Farber Cancer Institute in Boston. “When it spreads to vital organs, it’s almost always fatal.”
Unfortunately many people don’t think of skin cancer as a ‘killer’ and fail to protect themselves as well as they should. That’s why we’re committed to selling the highest SPF 150 rash guards and UV protective swim shirts available.




